Pfizer Inc's ability to collect accounts receivable sequentially worsen to 4.98, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Pfizer Inc's accounts receivable remained unchanged at 73 days, in the Jun 28 2026 quarter.

If we take a look into Healthcare sector 372 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 28 2026 from 2583 to 2650.

What is Receivable Turnover Ratio?
What is Pfizer Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PFE Receivables Turnover Ratio	(Jun 28 2026) II. Quarter	(Mar 29 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Receivable Change	3.41 %	6.25 %	3.59 %	-1.32 %	6.01 %
Y / Y Revenue Change	2.6 %	5.37 %	-1.16 %	-5.92 %	10.31 %
Receivable Turnover Ratio (TTM)	4.98	4.99	5	5.06	5.12
PFE's Total Ranking	# 2650	# 2583	# 2405	# 2483	# 1680
Accounts Receivable average collection period days	73	73	73	72	71
Seq. Receivable Change	-0.75 %	5.99 %	-16.73 %	18.07 %	1.97 %
Seq. Revenue Change	4.03 %	-17.69 %	5.42 %	13.66 %	6.84 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 112
Healthcare Sector	# 373
Overall Market	# 2650

Receivable Turnover Ratio Statistics
High	Average	Low
7.83	5.19	3.74
(Apr 03 2022)		(Sep. 30, 2009)

PFE Company Profile • Back to PFE Efficiency Comparisons • Compare PFE Receivables Turnover Ratio to its Competitors

Financial Statements
Pfizer Inc's Accounts Receivable	$ 12,490 Millions	Visit PFE's Balance sheet
Pfizer Inc's Sales TTM	$ 63,696 Millions	Visit PFE's Income Statement
Sources of PFE's Revenues		Visit PFE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PFE's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PFE's Growth Rates	PFE's Roa	PFE's Inventory Turnover Ratio	PFE's Dividend Comparisons
PFE's Profitability Ratios	PFE's Roi	PFE's Asset Turnover Ratio	PFE's Dividend Growth
PFE's Valuation Ratios	PFE's Roe	PFE's Financial Strength Ratios	PFE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 28 2026	Receivable at quarter ending Jun 28 2026
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Bioaffinity Technologies Inc	9.11	$ 5.901 Millions	$ 0.648 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biofrontera Inc	8.88	$ 45.956 Millions	$ 5.178 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions

Date modified: 2026-08-31T11:52:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.